Routine

Altitude travel with chronic lung disease

Altitude · pre-travel · Environmental
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Patients with COPD, interstitial lung disease, pulmonary hypertension or prior HAPE tolerate altitude poorly: the fall in inspired PO₂ worsens hypoxaemia and pulmonary-artery pressure. A pre-travel assessment predicts who will need supplemental oxygen or should avoid altitude.

Red flags

  • Resting hypoxaemia at sea level
  • Pulmonary hypertension
  • Prior HAPE
  • Recent exacerbation or unstable disease

Assessment

Differential diagnosis

  • Deconditioning
  • Cardiac disease
  • Anaemia
  • Pulmonary hypertension
  • Obstructive sleep apnoea / obesity-hypoventilation

Investigations

  • Spirometry / lung function and resting SpO₂
  • Sea-level ABG in advanced disease
  • Hypoxic challenge (altitude simulation) test where available — predicts in-flight/at-altitude PaO₂
  • Echocardiography if pulmonary hypertension suspected

Management

  • Assess severity and baseline oxygenation before travel; optimise the underlying disease first.
  • Predict altitude PaO₂ (hypoxic challenge test) — arrange supplemental oxygen if predicted PaO₂ is low.
  • Advise graded ascent, extra time to acclimatise, and avoiding heavy exertion early.
  • Continue inhalers/therapy; consider acetazolamide prophylaxis if also AMS-prone (caution in CO₂ retention).
  • Counsel on the symptoms of AMS/HAPE and a clear descent plan; those with severe disease or pulmonary hypertension may be advised NOT to travel to high altitude.

Drugs & doses

Supplemental oxygen (titrated to predicted need)
Continue usual bronchodilators / controller therapy
Acetazolamide 125 mg BD if AMS-prone (avoid in significant CO₂ retention)

Disposition

Outpatient respiratory assessment before travel; arrange oxygen provision and a written descent/action plan.

Complications & pitfalls

  • Severe hypoxaemia at altitude
  • Right-heart strain / decompensation
  • HAPE (esp. prior history)
  • Exacerbation of the underlying disease

Exam pearls

  • A hypoxic-challenge (altitude simulation) test is the best predictor of who needs oxygen.
  • Prior HAPE is the strongest risk factor for recurrence — plan prophylaxis and slow ascent.
  • Use acetazolamide cautiously in CO₂-retaining COPD.

This is a pre-travel risk assessment: optimise the lung disease, predict oxygen needs, plan graded ascent, and advise the highest-risk patients against altitude travel.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.